ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,849.72
-1.76%
US Tech 100
19,877.60
-0.02%
다우존스 지수
43,191.24
-1.48%
Bitcoin
83,929.50
-2.51%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Wolters Kluwers NV (WKL) 시세

Wolters Kluwers NV

Wolters Kluwers NV (WKL)

EU
148.55
-1.75
( -1.16% )
업데이트: 20:22:50
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
148.55
매수가
148.55
매도가
148.60
거래량
194,033
148.20 일간 변동폭 150.60
137.55 52주 범위 181.30
market_cap
34.82B
전일 종가
150.30
개장가
149.55
최근 거래 시간
5
@
148.55
마지막 거래 시간
20:22:50
재정 규모
-
VWAP
-
평균 볼륨(3m)
537,303
발행 주식
234,400,000
배당수익률
-
주가수익률
32.29
주당순이익(EPS)
4.6
매출
5.92B
순이익
1.08B

Wolters Kluwers NV 정보

섹터
Prepackaged Software
산업
Book Printing/publishing
웹사이트
www.wolterskluwer.com
본부
Alphen Aan Den Rijn, South Holland, Nld
설립됨
1986
Wolters Kluwers NV is listed in the Prepackaged Software sector of the 유로넥스트 (Euronext) with ticker WKL. The last closing price for Wolters Kluwers NV was 150.30 €. Over the last year, Wolters Kluwers NV shares have traded in a share price range of 137.55 € to 181.30 €.

Wolters Kluwers NV currently has 234,400,000 shares in issue. The market capitalisation of Wolters Kluwers NV is 35.23 € billion. Wolters Kluwers NV has a price to earnings ratio (PE ratio) of 32.29.

WKL 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-23.65-13.7340301974172.2172.65145.351475663152.99462013DE
4-25.95-14.8710601719174.5181.3145.35726096164.74273019DE
12-13.4-8.27415869095161.95181.3145.35537303165.26439706DE
26-4.65-3.03524804178153.2181.3145.35487992160.86899722DE
523.352.30716253444145.2181.3137.55447583154.89906414DE
15653.3556.039915966495.2181.384.24496326123.04721475DE
26079.91116.41899766968.64181.352.04527258103.49259925DE

WKL - Frequently Asked Questions (FAQ)

What is the current Wolters Kluwers NV share price?
The current share price of Wolters Kluwers NV is 148.55 €
How many Wolters Kluwers NV shares are in issue?
Wolters Kluwers NV has 234,400,000 shares in issue
What is the market cap of Wolters Kluwers NV?
The market capitalisation of Wolters Kluwers NV is EUR 35.23B
What is the 1 year trading range for Wolters Kluwers NV share price?
Wolters Kluwers NV has traded in the range of 137.55 € to 181.30 € during the past year
What is the PE ratio of Wolters Kluwers NV?
The price to earnings ratio of Wolters Kluwers NV is 32.29
What is the cash to sales ratio of Wolters Kluwers NV?
The cash to sales ratio of Wolters Kluwers NV is 5.89
What is the reporting currency for Wolters Kluwers NV?
Wolters Kluwers NV reports financial results in EUR
What is the latest annual turnover for Wolters Kluwers NV?
The latest annual turnover of Wolters Kluwers NV is EUR 5.92B
What is the latest annual profit for Wolters Kluwers NV?
The latest annual profit of Wolters Kluwers NV is EUR 1.08B
What is the registered address of Wolters Kluwers NV?
The registered address for Wolters Kluwers NV is ZUIDPOOLSINGEL 2, P.O. BOX 1030, ALPHEN AAN DEN RIJN, SOUTH HOLLAND, 2400 BA
What is the Wolters Kluwers NV website address?
The website address for Wolters Kluwers NV is www.wolterskluwer.com
Which industry sector does Wolters Kluwers NV operate in?
Wolters Kluwers NV operates in the BOOK PRINTING/PUBLISHING sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ETLEutelsat Communications
3.614 €
(79.27%)
6.39M
MEMSMemscap
4.80 €
(33.70%)
206.97k
LATLatecoere
0.0134 €
(32.67%)
45.8M
ALGIDEgide
0.64 €
(31.15%)
508.99k
ALORAAltheora
0.439 €
(21.94%)
122.98k
MLGEQGentlemen S Equity SA
0.012 €
(-64.71%)
316.91k
LUDSLucibel DS
0.0008 €
(-42.86%)
28.2k
ALADOAdomos
0.41 €
(-25.45%)
26.31k
ALSRSSirius Media
0.012 €
(-19.46%)
14.07M
ALBOOBOOSTHEAT
0.0076 €
(-19.15%)
360.99k
ATOAtos SE
0.0035 €
(6.06%)
1.71B
ALEUPEuroplasma
0.0123 €
(0.00%)
51.05M
LATLatecoere
0.0134 €
(32.67%)
45.8M
ALVERVergnet
0.0004 €
(0.00%)
41.28M
BCPBanco Comercial Portugues SA
0.5188 €
(-3.14%)
34.93M

토론

전체 피드 보기
gedi8 gedi8 4 분 전
We will see my friend. His first month in office has really hurt the market. I hope you are right
NXPL
WooptdooU WooptdooU 5 분 전
Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.
LWLG
louieforpar louieforpar 5 분 전
Less than four one way or another. 


glenn1919 glenn1919 6 분 전
INLF....................................................................................p/m
INLF
uranium-pinto-beans uranium-pinto-beans 7 분 전
OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve
OKTA
WooptdooU WooptdooU 7 분 전
These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.
LWLG
uranium-pinto-beans uranium-pinto-beans 8 분 전
mmmm


https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account
uranium-pinto-beans uranium-pinto-beans 9 분 전
OKTA
Okta price target raised to $100 from $94 at Canaccord
Canaccord raised the firm's price target on Okta to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported resoundingly positive Q4 results ahead of both the firm's and consensus expectations with
OKTA
uranium-pinto-beans uranium-pinto-beans 10 분 전
MCHP
Microchip cyclical bottom may be forming, says JPMorgan
Jefedejefes Jefedejefes 11 분 전
listening to your favorite song... over, and over, and over https://www.youtube.com/watch?v=BfnjX88Va4Y
EDXC
docj docj 15 분 전
"One example: the current CEO of Cytodyn was CMO under Nader Pourhassan the Frauder, and was fine with all his actions."

That is a false statement. It is a matter of public record how Dr JL felt about Nader. Stop trying to make it look like he was complicit with Nader's actions. It lo
CYDY
meixatech meixatech 16 분 전
"Oral bioavailability" is one of the most important properties in drug design and development. A high oral bioavailability reduces the amount of an administered drug necessary to achieve a desired pharmacological effect and therefore could reduce the risk of side-effects and toxicity.
RSPI
trader53 trader53 16 분 전
Nixon's Restaurants have not gone belly up


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
______________________________________________________________________


Nixon Restaurant Group Inc
is operated in Colorado ,
gp22 gp22 17 분 전
$ESLA @ $1.05....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s 2 weeks ago and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-complete-response-160000432.h
ESLA IOVA SMMT
WooptdooU WooptdooU 18 분 전
Grifter siraj...eom
LWLG
StockWorkOrange StockWorkOrange 21 분 전
Aw. Someone is upset their Picture Pump didn't work this time. Oh well. I'm sure you'll come up with something new to get these bAABBoons to hand over some more money.......
AABB
hedge_fun hedge_fun 22 분 전
They’ll need to be careful with their…….,

updates, won’t they?

They say the device pinpoints treasure, right?

If they’re diving and coming up empty, then Houston, don’t we have a problem?

Of course they could always be doing something wit
SFRX
StockWorkOrange StockWorkOrange 22 분 전
We all see how well you and the pump crew are doing on X with your 20 likes. Keep up the good work Alidare. It really seems to be working......#ticktock
AABB
glenn1919 glenn1919 22 분 전
AEON.......SPPL........RETO........PTIX.........................................................................p/m
PTIX RETO SPPL
WeTheMarket WeTheMarket 23 분 전
UK, any comments on the Earnings Report/10K? Are you still out and plan to stay out or do you see signs of hope for the future?
PLUG
glenn1919 glenn1919 24 분 전
AEON..........................................https://stockcharts.com/h-sc/ui?s=AEON&p=W&b=5&g=0&id=p86431144783
AEON
Jackxkr Jackxkr 24 분 전
At this moment what happens after approval is not as worrying as getting approval. As each day passes chances of approval goes down from here.
NWBO
edbi46 edbi46 27 분 전
On REDDIT 3 months ago:
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an el
BMI LMT QUBT

최근 히스토리

EU
WKL
Wolters Kluwers NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지